or
forgot password
  • cancer clinical trials in oklahoma

  • Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    University of Oklahoma Health Sciences Center

    Trial Locations
    University of Oklahoma Health Sciences Center
    Mercy Health Center
    Cancer Care Associates
    Natalie W Bryant Cancer Center
    Saint John Medical Center
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    A Trial of Paclitaxel and Bevacizumab vs. Gemcitabine, Paclitaxel, and Bevacizumab in Advanced Breast Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Tulsa, Oklahoma 74136
    Breast Cancer
    Bevacizumab, Radiation Therapy, and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Nonmetastatic Rectal Cancer
    Natalie W Bryant Cancer Center
    Tulsa, Oklahoma 74136
    Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Cancer Centers of Southwest Oklahoma Research

    Trial Locations
    Cancer Centers of Southwest Oklahoma Research
    Cancer Care Associates-Norman
    University of Oklahoma Health Sciences Center
    Cancer Care Associates-Mercy
    Mercy Physicians of Oklahoma-Lakeside
    Natalie W Bryant Cancer Center
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Cancer Care Associates

    Trial Locations
    Cancer Care Associates
    Natalie W Bryant Cancer Center
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    PRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Tulsa, Oklahoma 74136
    Non Hodgkin Lymphoma
    Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors
    Oklahoma University Cancer Institute

    Trial Locations
    Oklahoma University Cancer Institute
    Natalie Warren Bryant Cancer Center at St. Francis Hospital
    Kidney Cancer
    Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Adult Alveolar Soft-part Sarcoma, Adult Angiosarcoma, Adult Epithelioid Sarcoma, Adult Extraskeletal Chondrosarcoma, Adult Extraskeletal Osteosarcoma, Adult Fibrosarcoma, Adult Leiomyosarcoma, Adult Liposarcoma, Adult Malignant Fibrous Histiocytoma, Adult Malignant Hemangiopericytoma, Adult Malignant Mesenchymoma, Adult Neurofibrosarcoma, Adult Synovial Sarcoma, Childhood Alveolar Soft-part Sarcoma, Childhood Angiosarcoma, Childhood Epithelioid Sarcoma, Childhood Fibrosarcoma, Childhood Leiomyosarcoma, Childhood Liposarcoma, Childhood Malignant Mesenchymoma, Childhood Neurofibrosarcoma, Childhood Synovial Sarcoma, Chondrosarcoma, Dermatofibrosarcoma Protuberans, Localized Childhood Malignant Fibrous Histiocytoma of Bone, Metastatic Childhood Malignant Fibrous Histiocytoma of Bone, Metastatic Childhood Soft Tissue Sarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma
    BB-10901 in Treating Patients With Relapsed or Refractory Solid Tumors
    Oklahoma University
    Tulsa, Oklahoma 74104
    Ovarian Cancer, Merkel Cell Carcinoma, SCLC
    Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
    University of Oklahoma Health Sciences Center

    Trial Locations
    University of Oklahoma Health Sciences Center
    Natalie W Bryant Cancer Center
    Stage I Wilms Tumor, Stage II Wilms Tumor, Stage III Wilms Tumor
    Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
    Natalie W Bryant Cancer Center
    Tulsa, Oklahoma 74136
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer
    Natalie Warren Bryant Cancer Center at St. Francis Hospital
    Tulsa, Oklahoma 74136
    Breast Cancer, Lung Cancer, Metastatic Cancer, Pain, Prostate Cancer
    Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Leukemia, Myelodysplastic Syndromes
    Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
    University of Oklahoma Health Sciences Center

    Trial Locations
    University of Oklahoma Health Sciences Center
    Natalie W Bryant Cancer Center
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer
    S0500 Treatment Decision Making Based on Blood Levels of Tumor Cells in Women With Metastatic Breast Cancer Receiving Chemotherapy
    Natalie Warren Bryant Cancer Center at St. Francis Hospital
    Tulsa, Oklahoma 74136
    Breast Cancer
    Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
    Cleo Craig Cancer Research Clinic

    Trial Locations
    Cleo Craig Cancer Research Clinic
    Natalie Warren Bryant Cancer Center at St. Francis Hospital
    Breast Cancer
    Enzastaurin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
    University of Oklahoma Health Sciences Center

    Trial Locations
    University of Oklahoma Health Sciences Center
    Natalie W Bryant Cancer Center
    Contiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Stage II Adult T-cell Leukemia/Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Adult T-cell Leukemia/Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Adult T-cell Leukemia/Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, T-cell Adult Acute Lymphoblastic Leukemia, T-cell Childhood Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    Fludeoxyglucose F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Small Cell Carcinoma, Cervical Squamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, Endometrial Papillary Serous Carcinoma, Stage I Endometrial Carcinoma, Stage IB Cervical Cancer, Stage II Endometrial Carcinoma, Stage IIA Cervical Cancer, Stage IIB Cervical Cancer, Stage III Cervical Cancer, Stage III Endometrial Carcinoma, Stage IVA Cervical Cancer
    AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors
    Natalie Warren Bryant Cancer Center at St. Francis Hospital
    Tulsa, Oklahoma 74136
    Gastrointestinal Carcinoid Tumor, Islet Cell Tumor, Neoplastic Syndrome
    Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Prostate Cancer
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Cancer Centers of Southwest Oklahoma Research

    Trial Locations
    Cancer Centers of Southwest Oklahoma Research
    Cancer Care Associates-Norman
    University of Oklahoma Health Sciences Center
    Cancer Care Associates-Mercy
    Mercy Physicians of Oklahoma-Lakeside
    Cancer Care Associates
    Natalie W Bryant Cancer Center
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    Levonorgestrel in Preventing Ovarian Cancer in Patients at High Risk for Ovarian Cancer
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Ovarian Cancer
    PARTNER: Panitumumab Added to Regimen for Treatment of Head aNd Neck Cancer Evaluation of Response
    Research Site
    Enid, Oklahoma
    Metastatic or Recurrent Squamous Cell Carcinoma of Head and Neck
    Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Ototoxicity, Unspecified Childhood Solid Tumor, Protocol Specific
    Glycoprotein and Glycan in Patients With Stage I, Stage II, Stage III, or Stage IV Cervical Cancer Undergoing Surgery to Remove Pelvic and Abdominal Lymph Nodes
    Oklahoma University Cancer Institute

    Trial Locations
    Oklahoma University Cancer Institute
    Cancer Care Associates - Saint Francis Campus
    Cervical Cancer
    VEGF Trap in Treating Patients With Recurrent or Persistent Endometrial Cancer
    Cancer Care Associates-Midtown
    Tulsa, Oklahoma 74104
    Recurrent Endometrial Carcinoma
    ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox
    Oklahoma State University Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Anemia
    Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Ovarian Cancer, Testicular Germ Cell Tumor